CN110003355B - Glucan derivative with AIE characteristic and synthesis method and application thereof - Google Patents
Glucan derivative with AIE characteristic and synthesis method and application thereof Download PDFInfo
- Publication number
- CN110003355B CN110003355B CN201910291713.0A CN201910291713A CN110003355B CN 110003355 B CN110003355 B CN 110003355B CN 201910291713 A CN201910291713 A CN 201910291713A CN 110003355 B CN110003355 B CN 110003355B
- Authority
- CN
- China
- Prior art keywords
- aie
- dextran
- derivative
- glucan
- stirring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229920001503 Glucan Polymers 0.000 title claims abstract description 31
- 238000001308 synthesis method Methods 0.000 title abstract description 5
- 238000004220 aggregation Methods 0.000 claims abstract description 11
- 230000002776 aggregation Effects 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 238000003384 imaging method Methods 0.000 claims abstract description 9
- 239000000693 micelle Substances 0.000 claims abstract description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 39
- 238000006243 chemical reaction Methods 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 9
- 229920002307 Dextran Polymers 0.000 claims description 7
- 229940125904 compound 1 Drugs 0.000 claims description 7
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 4
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 238000000502 dialysis Methods 0.000 claims description 3
- 239000007850 fluorescent dye Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- -1 4-formylphenyl Chemical group 0.000 claims description 2
- 238000005886 esterification reaction Methods 0.000 claims description 2
- 238000004020 luminiscence type Methods 0.000 claims 1
- 238000011160 research Methods 0.000 abstract description 7
- 239000000243 solution Substances 0.000 description 18
- 239000007864 aqueous solution Substances 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002189 fluorescence spectrum Methods 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- 238000012984 biological imaging Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000002073 fluorescence micrograph Methods 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 239000002539 nanocarrier Substances 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/14—Macromolecular compounds
- C09K2211/1441—Heterocyclic
- C09K2211/145—Heterocyclic containing oxygen as the only heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/14—Macromolecular compounds
- C09K2211/1441—Heterocyclic
- C09K2211/1466—Heterocyclic containing nitrogen as the only heteroatom
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
The invention discloses a glucan derivative with AIE characteristics, a synthesis method and application thereof, wherein the structure of the glucan derivative with AIE characteristicsThe formula is as follows:wherein x is 59.4 and y is 1.6. The glucan derivative having the AIE characteristics of the present invention is soluble in water and has a low critical micelle concentration of 5X 10‑3mg/mL, has good aggregation-induced emission characteristics at low concentration, and has concentration range of 1 × 10‑3mg/mL to 60X 10‑3mg/mL, has important research value in the fields of cell imaging and related research.
Description
Technical Field
The invention relates to a glucan derivative with AIE characteristics, a synthesis method and application thereof, and belongs to the technical field of fluorescent materials.
Background
In recent years, with the continuous development of biological imaging technology, the nano-carrier with imaging function is receiving attention from researchers. However, the conventional fluorescent probe is affected by the aggregation quenching (ACQ) effect, and the fluorescence efficiency thereof is significantly reduced at a high concentration, so that the detection and analysis means using fluorescence as an output signal is severely restricted. However, researchers have discovered a new fluorescent molecule that emits strong fluorescence intensity in an aggregated state, and this new fluorescent molecule can avoid the phenomenon of fluorescence quenching that occurs in conventional fluorescent molecules at high concentrations, which is called aggregation-induced emission (AIE) effect. The researchers have generated great interest in the fluorescent molecules, and as the research goes into, the researchers have developed systems with aggregation-induced emission effect in the whole visible wavelength range, and these systems with AIE are widely applied to the fields of cell imaging and related research.
However, the AIE systems reported to date have focused primarily on small molecules and organic polymers with pi conjugated groups. These molecules containing pi conjugated groups not only have poor water solubility for biological applications, but also have great cytotoxicity, and these disadvantages severely limit their application in the biomedical field. On the other hand, few researchers report that amphiphilic fluorescent molecules with aggregation-induced emission properties can self-assemble to form nano-micelles with hydrophobic cores and hydrophilic shells in aqueous solution, and form amphiphilic molecules with small molecular fluorescent compounds with AIE characteristics and hydrophilic substances, and structurally, the amphiphilic molecules contain both hydrophobic fluorescent compounds with AIE characteristics and hydrophilic structural units. The glucan molecule can be compatible with biological tissues because the glucan molecule chain contains a large amount of hydrophilic hydroxyl groups and can be degraded under the action of enzyme, and the glucan can be used as a carrier due to the hydrophilicity and biocompatibility of the glucan and is widely applied to the field of biological imaging.
Since researchers do not have long time to recognize aggregation-induced emission, the compounds synthesized to date have limited species and relatively single structures.
Disclosure of Invention
The invention aims to provide a glucan derivative with AIE characteristics, a synthesis method and application thereof. The invention synthesizes a novel compound with aggregation induction characteristic through molecular design, and the compound which forms amphipathy with glucan can be used for cell imaging and related research fields.
The invention relates to a glucan derivative with AIE characteristics, which has the following structural formula:
wherein x is 59.4 and y is 1.6.
The invention relates to a preparation method of a glucan derivative with AIE characteristics, which is characterized in that glucan and a compound 1-N-hydroxyethyl-4- (4-formylphenyl) -1, 8-naphthalimide with AIE characteristics are subjected to esterification reaction through Carbonyl Diimidazole (CDI) to obtain a target product.
The structural formula of the compound 1 is as follows:
the preparation method of the glucan derivative with the AIE characteristic comprises the following steps:
step 1: the reaction apparatus was dried thoroughly in an oven at 120 ℃ and placed in a desiccator to cool to room temperature. 0.194g (1.2mmol) of CDI and 3ml of anhydrous DMSO are added into a round-bottom flask, and the mixture is stirred and uniformly dispersed; accurately weighing 0.345g (1mmol) of compound 1, completely dissolving in 8ml of anhydrous DMSO, slowly dropwise adding the compound into a round-bottom flask by using a constant-pressure funnel, and stirring for reaction for 3 hours at normal temperature;
step 2: 0.31g of dextran was weighed into a completely dry reactor, and a suitable amount of anhydrous DMSO was added in N2Heating and stirring the mixture under protection until the glucan is completely dissolved, then slowly dripping the reaction solution obtained in the step (1) into the reactor, and stirring the mixture to react for 24 hours at the temperature of 70 ℃; the reaction solution was transferred to a dialysis bag and dialyzed first in DMSO solution for 24h and then in deionized water for 72h, the dialysate was changed once for 8h, and the product was freeze-dried.
The synthetic route of the target product of the invention is as follows:
the application of the glucan derivative with the AIE characteristic is the application of the glucan derivative as a fluorescent probe in the cell imaging process.
The glucan derivative having the AIE characteristics of the present invention is soluble in water and has a low critical micelle concentration of 5X 10-3mg/mL, has good aggregation-induced emission characteristics at low concentration, and has concentration range of 1 × 10-3mg/mL to 60X 10-3mg/mL, has important research value in the fields of cell imaging and related research.
Compared with the prior art, the invention has the beneficial effects that:
the invention selects a novel micromolecule compound with aggregation-induced emission characteristic, forms an amphiphilic glucan derivative with glucan, has good solubility in aqueous solution, can form autofluorescence nano-micelle when the concentration in the aqueous solution is higher than the critical micelle concentration, and can be used as an autofluorescence probe for intracellular imaging.
Drawings
FIG. 1 is an infrared spectrum of a glucan derivative having AIE characteristics according to the present invention.
FIG. 2 shows the nuclear magnetic hydrogen spectrum of the dextran derivative having AIE characteristics according to the present invention.
FIG. 3 shows the fluorescence spectra (. lamda.) of aqueous solutions of different concentrations of dextran derivatives with AIE characteristicsex=360nm)。
FIG. 4 is a graph of the fluorescence intensity at 460nm versus the log concentration (lambda) of different concentrations of a dextran derivative with AIE characteristicsex=360nm)。
FIG. 5 is a photo-bleaching graph of dextran derivatives with AIE characteristics according to the present invention.
FIG. 6 is a confocal image of HeLa cells. Among them, a fluorescence image (a), a superposition of fluorescence and bright field images (B), and a bright field image (C) of HeLa cells.
Detailed Description
The invention is further illustrated by, but is not limited to, the following examples.
Example 1: preparation of dextran derivatives with AIE characteristics
1. The reaction apparatus was dried thoroughly in an oven at 120 ℃ and placed in a desiccator to cool to room temperature. 0.194g (1.2mmol) of CDI and 3ml of anhydrous DMSO are added into a round-bottom flask, and the mixture is stirred and uniformly dispersed; 0.345g (1mmol) of Compound 1 was accurately weighed out and completely dissolved in 8ml of anhydrous DMSO, and slowly added dropwise to a round-bottomed flask using a constant pressure funnel, and the reaction was stirred at room temperature for 3 hours.
2. Another accurately weighed 0.31g dextran in a completely dry three-necked flask, added with a proper amount of anhydrous DMSO in N2Heating and stirring under protection until the glucan is completely dissolved, and obtaining the product in the step 1Placing the obtained reaction solution in a constant pressure funnel, slowly dripping the reaction solution into a round-bottom flask, and stirring the reaction solution at the temperature of 70 ℃ for 24 hours; the reaction was transferred to a dialysis bag and first dialyzed in DMSO for about 24h, then in deionized water for 72h, the dialysate was changed once for 8h, and the product was freeze-dried.
FIG. 1 is an infrared spectrum of a Dextran derivative with AIE characteristics (Dextran: Dextran, Dex-CHO: Dextran fluorescent marker). FT-IR (KBr, cm)-1): 3400(O-H stretching vibration, 2929 (-CH)2Stretching vibration), indicating that the hydroxyl group of the raw material glucan is reacted by the fact that the O-H peak of the product is weaker than that of the raw material glucan as compared with the raw material. At 1747cm-1There is a newly formed peak of ester groups, demonstrating successful synthesis of the product.
FIG. 2 is a nuclear magnetic hydrogen spectrum of a glucan derivative having AIE characteristics. The solvent chosen was DMSO-d6, 3.2-4.9 ppm-CH belonging to dextran2and-OH peaks, 7.8-8.5ppm belonging to hydrogen on naphthalene and benzene rings of Compound 1, 10.1ppm belonging to-CHO peaks of Compound 1, indicating successful synthesis of the product.
Example 2: aggregation-induced emission properties of dextran derivatives with AIE characteristics
Accurately weighing 20mg of target product, completely dissolving the target product in DMSO solvent to prepare a stock solution with a concentration of 25mg/mL, diluting the stock solution with water to obtain a solution to be detected with a concentration of 1mg/mL, putting 4mL of pure water into PE tubes, respectively adding 4 muL, 8 muL, 12 muL, 20 muL, 28 muL, 36 muL, 48 muL and 72 muL of solutions to be detected with a concentration of 1mg/mL into each PE tube, and respectively taking 3.84mL and 3.76mLH2O adding 160 μ L and 240 μ L of solution to be tested with concentration of 1mg/mL into two PE tubes, shaking to obtain solutions to be tested with different concentrations, measuring fluorescence spectra of the solutions to be tested (as shown in FIG. 3), increasing the concentration of the solution to gradually increase the fluorescence intensity of the dextran derivative with AIE characteristic at λex360 nm. The inset is a concentration of 10 × 10-3Photograph of mg/mL solution under 365nm UV lamp.
FIG. 4 is the fluorescence emission spectra and concentrations of different concentrations of dextran derivatives with AIE characteristicsLogarithmic graph, CMC is 5X 10-3mg/mL, indicating that the product has a lower critical micelle concentration.
Example 3: photobleaching experiments with dextran derivatives with AIE characteristics
1.6mL of the 1mg/mL test solution obtained in example 2 was added dropwise to 80mL of water to prepare a 20X 10 concentration solution-3Stirring mg/mL solution under 365 ultraviolet lamp, and measuring fluorescence intensity (lambda) by taking 3-4mL solution at certain time intervalsem360nm), and its fluorescence intensity I (as shown in fig. 5) was measured over 8h0The fluorescence intensity of the solution to be detected is represented when the illumination time is 0, and the fluorescence intensity of the solution to be detected is found to slightly decrease and then tend to be stable within 8 hours, which indicates that the solution has good photobleaching resistance.
Example 4: cellular imaging of dextran derivatives with AIE characteristics
FIG. 6 is a confocal laser microscopy image of HeLa cells treated for 30min with the dextran derivative with AIE characteristics, A being a fluorescence field image, B being the superposition of fluorescence and bright field images, and C being a bright field image. As can be seen from FIG. 6A, the dextran derivative emitted a significant blue fluorescence in HeLa cells under 406nm laser excitation. As can be seen from FIG. 6C, the cells co-cultured with the glucan derivative maintained their cell morphology well, indicating that the glucan was very biocompatible.
Claims (6)
2. A method of preparing the AIE-characterized glucan derivative of claim 1, wherein:
the target product is obtained by esterification reaction of dextran and compound 1-N-ethoxyl-4- (4-formylphenyl) -1, 8-naphthalimide with AIE characteristic through carbonyl diimidazole;
the structural formula of the compound 1 is as follows:
3. the method of claim 2, comprising the steps of:
step 1: adding 1.2mmol of CDI and anhydrous DMSO into a completely dry round-bottom flask, and uniformly stirring and dispersing; weighing 1mmol of compound 1, completely dissolving in anhydrous DMSO, slowly dropwise adding into a round-bottom flask by using a constant-pressure funnel, and reacting for 3h under stirring at normal temperature;
step 2: 0.31g of dextran was weighed into a completely dry reactor, anhydrous DMSO was added in N2Heating and stirring the mixture under protection until the glucan is completely dissolved, then slowly dripping the reaction solution obtained in the step (1) into the reactor, and stirring the mixture to react for 24 hours at the temperature of 70 ℃; the reaction solution was transferred to a dialysis bag and dialyzed first in DMSO solution for 24h and then in deionized water for 72h, the dialysate was changed once for 8h, and the product was freeze-dried.
4. Use of the dextran derivative with AIE characteristics according to claim 1, characterized in that: the dextran derivative is used as a fluorescent probe in a cell imaging process.
5. Use according to claim 4, characterized in that:
the dextran derivative is soluble in water at 1 × 10-3mg/mL to 60X 10-3Has obvious aggregation-induced luminescence characteristics in the concentration range of mg/mL.
6. Use according to claim 4, characterized in that:
the critical micelle concentration of the dextran derivative is 5 × 10-3mg/mL。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910291713.0A CN110003355B (en) | 2019-04-12 | 2019-04-12 | Glucan derivative with AIE characteristic and synthesis method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910291713.0A CN110003355B (en) | 2019-04-12 | 2019-04-12 | Glucan derivative with AIE characteristic and synthesis method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110003355A CN110003355A (en) | 2019-07-12 |
CN110003355B true CN110003355B (en) | 2020-12-11 |
Family
ID=67171251
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910291713.0A Active CN110003355B (en) | 2019-04-12 | 2019-04-12 | Glucan derivative with AIE characteristic and synthesis method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110003355B (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050214807A1 (en) * | 2003-11-19 | 2005-09-29 | Iain Johnson | Environmental sensitive fluorogenic compounds and their application for singlet oxygen and protein detection |
CN108774301A (en) * | 2018-07-11 | 2018-11-09 | 西南大学 | The preparation method and applications of sour responsive polymer drug of the one kind based on glucan |
-
2019
- 2019-04-12 CN CN201910291713.0A patent/CN110003355B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN110003355A (en) | 2019-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pan et al. | Near-infrared emissive carbon dots for two-photon fluorescence bioimaging | |
Shulov et al. | Fluorinated counterion-enhanced emission of rhodamine aggregates: ultrabright nanoparticles for bioimaging and light-harvesting | |
Li et al. | Polyhedral oligomeric silsesquioxanes‐containing conjugated polymer loaded PLGA nanoparticles with trastuzumab (herceptin) functionalization for HER2‐positive cancer cell detection | |
Wan et al. | Facile fabrication of amphiphilic AIE active glucan via formation of dynamic bonds: self assembly, stimuli responsiveness and biological imaging | |
Zhang et al. | Renewable itaconic acid based cross-linked fluorescent polymeric nanoparticles for cell imaging | |
Wang et al. | Red fluorescent cross-linked glycopolymer nanoparticles based on aggregation induced emission dyes for cell imaging | |
US20080242806A1 (en) | Water-Soluble Fluorescent Particle Comprising Entangled Fluorescent Polymer and Amphiphilic Molecule | |
CN113105349B (en) | Luminescent compound with aggregation induction and supermolecule polymerization fluorescent nano material and preparation method thereof | |
CN110194822B (en) | Preparation and application of temperature-sensitive type dual-fluorescence Pdots based on single-arm TPE molecules | |
Zhou et al. | Azoreductase-triggered fluorescent nanoprobe synthesized by RAFT-mediated polymerization-induced self-assembly for drug release | |
Liu et al. | Autofluorescent micelles self-assembled from an AIE-active luminogen containing an intrinsic unconventional fluorophore | |
WO2018103262A1 (en) | Extracellular ratio-type oxygen sensing probe and preparation method and use thereof | |
Zhang et al. | Facile fabrication of aggregation-induced emission based red fluorescent organic nanoparticles for cell imaging | |
Li et al. | Preparation of glucose-responsive and fluorescent micelles via a combination of RAFT polymerization and chemoenzymatic transesterification for controlled release of insulin | |
CN114656424B (en) | Up-conversion long-afterglow chemiluminescent imaging nano probe and preparation method and application thereof | |
CN109321240A (en) | A kind of fluorescent orange carbon dots and preparation method thereof | |
Zhang et al. | A novel fluorescent amphiphilic glycopolymer based on a facile combination of isocyanate and glucosamine | |
Wang et al. | A biocompatible poly (N-vinylimidazole)-dot with both strong luminescence and good catalytic activity | |
Li et al. | Fluorescent polymeric nanoparticles with ultra-low CMC for cell imaging | |
Zhang et al. | Biocompatible fluorescent organic nanoparticles derived from glucose and polyethylenimine | |
Deng et al. | Polymeric nanoparticles based on CDs with photoreversible dual-color fluorescence modulation | |
CN114621159A (en) | Diazosulfide-based fluorescent material, fluorescent polymer, fluorescent nanoparticles, and preparation method and application thereof | |
Rossi et al. | Carbon quantum dots: An environmentally friendly and valued approach to sludge disposal | |
Hui et al. | Supermolecular self assembly of AIE-active nanoprobes: fabrication and bioimaging applications | |
CN110003355B (en) | Glucan derivative with AIE characteristic and synthesis method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |